Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;33(1):112-118.
doi: 10.1111/pcmr.12830. Epub 2019 Oct 28.

ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation

Affiliations

ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation

Pakavarin Louphrasitthiphol et al. Pigment Cell Melanoma Res. 2020 Jan.

Abstract

Defining markers of different phenotypic states in melanoma is important for understanding disease progression, determining the response to therapy, and defining the molecular mechanisms underpinning phenotype-switching driven by the changing intratumor microenvironment. The ABCB5 transporter is implicated in drug-resistance and has been identified as a marker of melanoma-initiating cells. Indeed ongoing studies are using ABCB5 to define stem cell populations. However, we show here that the ABCB5 is a direct target for the microphthalmia-associated transcription factor MITF and its expression can be induced by β-catenin, a key activator and co-factor for MITF. Consequently, ABCB5 mRNA expression is primarily associated with melanoma cells exhibiting differentiation markers. The results suggest first that ABCB5 is unlikely to represent a marker of de-differentiated melanoma stem cells, and second that ABCB5 may contribute to the non-genetic drug-resistance associated with highly differentiated melanoma cells. To reconcile the apparently conflicting observations in the field, we propose a model in which ABCB5 may mark a slow-cycling differentiated population of melanoma cells.

Keywords: ABCB5; MITF; melanoma; stem cells; β-catenin.

PubMed Disclaimer

References

REFERENCES

    1. Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., … Bressac-de Paillerets, B. (2011). A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature, 480, 94-98. https://doi.org/10.1038/nature10539
    1. Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., … Weissman, I. L. (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature, 466, 133-137. https://doi.org/10.1038/nature09161
    1. Carreira, S., Goodall, J., Aksan, I., La Rocca, S. A., Galibert, M. D., Denat, L., … Goding, C. R. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature, 433, 764-769. https://doi.org/10.1038/nature03269
    1. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., … Goding, C. R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes & Development, 20, 3426-3439. https://doi.org/10.1101/gad.406406
    1. Cheli, Y., Bonnazi, V. F., Jacquel, A., Allegra, M., De Donatis, G. M., Bahadoran, P., … Ballotti, R. (2014). CD271 is an imperfect marker for melanoma initiating cells. Oncotarget, 5, 5272-5283. https://doi.org/10.18632/oncotarget.1967

Publication types

MeSH terms

Substances